Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Johannesburg Stock Exchange  >  Aspen Pharmacare Holdings Limited    APNJ   ZAE000066692

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Johannesburg Stock Exchan…
05/19/2017 05/22/2017 05/23/2017 05/24/2017 05/25/2017 Date
274 276 279.98 282.66 290.05 Last
1720635 1716570 1012764 1032092 1063886 Volume
-0.90% +0.73% +1.44% +0.96% +2.61% Change
Financials ( ZAR)
Sales 2017 41 835 M
EBIT 2017 10 313 M
Net income 2017 6 417 M
Debt 2017 37 520 M
Yield 2017 0,95%
Sales 2018 46 782 M
EBIT 2018 12 023 M
Net income 2018 8 232 M
Debt 2018 33 714 M
Yield 2018 1,14%
P/E ratio 2017 20,16
P/E ratio 2018 15,91
EV / Sales2017 4,06x
EV / Sales2018 3,55x
Capitalization 132 389 M
More Financials
Company
Aspen Pharmacare Holdings Ltd. engages in the manufacture and supply of branded and generic pharmaceutical products.The firm operates through the following segments: International, South Africa, Asia Pacific, and Sub-Saharan Africa.Its products include anaesthetics, analgesics, antiretrovirals,... 
Sector
Pharmaceuticals
Calendar
09/13Earnings Release
More about the company
Surperformance© ratings of Aspen Pharmacare Holdings
Trading Rating : Investor Rating :
More Ratings
Latest news on ASPEN PHARMACARE HOLDINGS
05/17 ASPEN PHARMACARE : Association of the British Pharmaceutical Industry Issues Sta..
05/16 ASPEN PHARMACARE : Eu commission probes aspen cancer drug hikes
05/15DJASPEN PHARMACARE : EU Opens Formal Probe Into Aspen Pharma's Pricing Practices f..
05/15DJASPEN PHARMACARE : EU Opens Formal Probe Into Aspen Pharma's Pricing Practices f..
04/24 ASPEN PHARMACARE : response to the reported Competition Commission investigation
04/24 ASPEN PHARMACARE : welcomes probe
04/20 ASPEN PHARMACARE : DA wants Aspen probed for allegedly discarding life-saving ca..
04/17 ASPEN PHARMACARE : Statement in response to The Times reports of 14 April 2017
03/13 ASPEN PHARMACARE : Chinese sales may reach R2bn
03/03ASPEN PHARMACARE HOLDINGS LIMITED : half-yearly earnings release
More news
Sector news : Generic Pharmaceuticals
02:43pDJSUN PHARMACEUTICAL INDUSTRIES : Pharma 4Q Profit Falls 13.6%
05/24 JOHNSON & JOHNSON : J&J settles drug manufacturing probe by U.S. states for $33 ..
05/24 FTSE edges up helped by M&S, but miners weigh
05/23DJMERCK : FDA OKs Merck's Keytruda to Treat Cancers With Genetic Defects -- Update
05/23DJMERCK : FDA Approves Merck's Keytruda to Treat Cancers With Genetic Defects
More sector news : Generic Pharmaceuticals
Latest Tweets
05/17Aspen Pharmacare Has Continued To Grow And Branch Out  
05/16Aspen Pharmacare hit by EU antitrust cancer drug price probe
1
05/15Aspen Pharmacare faces EU probe over cancer drug price rises
5
05/15Aspen Pharmacare faces EU probe over cancer drug price rises  
05/03Kuseni Dlamini: If South Africa and Nigeria collaborate they can transform Af..
10
More tweets
Qtime:84
News from SeekingAlpha
05/17 Aspen Pharmacare Has Continued To Grow And Branch Out
2016 Wobbles Aside, Small Pharma Shares Broadly On The Up In 2015
2015 Sector's Smaller Players Show The Way
2015 OPPORTUNITIES AND RISKS IN THE BIOTE : 2 Companies In South Africa
2015 SEEKING ALPHA'S BIOTECH WEEKLY : Deeper Looks At Orexigen, Pharmacyclics, And Ac..
Advertisement
Chart ASPEN PHARMACARE HOLDINGS
Duration : Period :
Aspen Pharmacare Holdings  Technical Analysis Chart | APNJ | ZAE000066692 | 4-Traders
Full-screen chart
Technical analysis trends ASPEN PHARMACARE ...
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 327  ZAR
Spread / Average Target 13%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stephen Bradley Saad Group Chief Executive Officer & Executive Director
Douglas Dlamini Chairman
Lorraine Hill Group Operating Officer
Sean Capazorio Group Finance Officer
Michael Guy Attridge Executive Director & Group Deputy CEO
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASPEN PHARMACARE HOLDI..2.25%10 229
OTSUKA HOLDINGS CO LTD0.90%25 726
SUN PHARMACEUTICAL IND..-2.14%21 967
ONO PHARMACEUTICAL CO...-8.48%12 381
SHANGHAI FOSUN PHARMAC..36.13%11 049
TAISHO PHARMACEUTICAL ..-9.68%7 094
More Results